San Diego-based Viking Therapeutics marked itself as a serious competitor in the weight loss drug sector in February right after revealing promising data from a mid-stage trial of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in March the company unvei